Sharecare Future Growth

Future criteria checks 0/6

Sharecare wird ein jährliches Wachstum der Erträge und Einnahmen um 50.4% bzw. 8.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich grow um 40.2% pro Jahr steigen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -5.9% betragen.

Key information

25.5%

Earnings growth rate

10.9%

EPS growth rate

Healthcare Services earnings growth26.4%
Revenue growth rate5.3%
Future return on equity-3.6%
Analyst coverage

Low

Last updated01 Apr 2024

Recent future growth updates

Recent updates

We Think Sharecare (NASDAQ:SHCR) Can Afford To Drive Business Growth

Nov 23
We Think Sharecare (NASDAQ:SHCR) Can Afford To Drive Business Growth

We're Hopeful That Sharecare (NASDAQ:SHCR) Will Use Its Cash Wisely

Aug 18
We're Hopeful That Sharecare (NASDAQ:SHCR) Will Use Its Cash Wisely

There's No Escaping Sharecare, Inc.'s (NASDAQ:SHCR) Muted Revenues

Jul 22
There's No Escaping Sharecare, Inc.'s (NASDAQ:SHCR) Muted Revenues

We Think Sharecare (NASDAQ:SHCR) Needs To Drive Business Growth Carefully

Feb 22
We Think Sharecare (NASDAQ:SHCR) Needs To Drive Business Growth Carefully

Sharecare awarded three-year NCQA accreditation for wellness and health promotion

Sep 19

Sharecare Non-GAAP EPS of -$0.02 beats by $0.07, revenue of $103.8M beats by $0.87M

Aug 10

Analysts Have Lowered Expectations For Sharecare, Inc. (NASDAQ:SHCR) After Its Latest Results

Apr 03
Analysts Have Lowered Expectations For Sharecare, Inc. (NASDAQ:SHCR) After Its Latest Results

Sharecare, Inc. (NASDAQ:SHCR) Analysts Just Slashed This Year's Estimates

Apr 02
Sharecare, Inc. (NASDAQ:SHCR) Analysts Just Slashed This Year's Estimates

Sharecare CEO Jeff Arnold - Healthcare Ripe For Disruption (Video)

Nov 23

Earnings and Revenue Growth Forecasts

NasdaqGS:SHCR - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025494-76N/AN/A3
12/31/2024431-108N/AN/A2
12/31/2023445-128-43-14N/A
9/30/2023463-118-66-30N/A
6/30/2023465-121-66-31N/A
3/31/2023458-115-103-61N/A
12/31/2022442-119-94-50N/A
9/30/2022438-85-111-64N/A
6/30/2022429-101-143-94N/A
3/31/2022423-92-104-62N/A
12/31/2021413-85-95-54N/A
9/30/2021383-123-56-26N/A
6/30/2021357-86-1410N/A
3/31/2021337-80-118N/A
12/31/2020329-61-315N/A
9/30/2020332-42-315N/A
12/31/2019340-40-143N/A
12/31/2018342-56-52-34N/A

Analyst Future Growth Forecasts

Einkommen vs. Sparrate: SHCR wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: SHCR wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: SHCR wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: SHCRDie Einnahmen des Unternehmens (8.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.2% pro Jahr).

Hohe Wachstumseinnahmen: SHCRDie Einnahmen des Unternehmens (8.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Earnings per Share Growth Forecasts


Future Return on Equity

Künftige Eigenkapitalrendite: SHCR wird voraussichtlich in 3 Jahren unrentabel sein.


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.